|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01226810 |
|
Date of registration:
|
21/10/2010 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to Exploration
|
|
Scientific title:
|
A Novel Approach to Ultrafast Parathyroid SPECT Imaging Using a Solid State CZT SPECT Camera |
|
Date of first enrolment:
|
January 2011 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01226810 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Cross-Sectional
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Kinga Przewloka, MSc |
|
Address:
|
|
|
Telephone:
|
009728542816 |
|
Email:
|
k_przewloka@rambam.health.gov.il |
|
Affiliation:
|
|
|
|
Name:
|
Ora Israel, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Rambam Health Care Campus |
|
|
Name:
|
Kinga Przewloka, MSc |
|
Address:
|
|
|
Telephone:
|
+9728542816 |
|
Email:
|
k_przewloka@rambam.health.gov.il |
|
Affiliation:
|
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1) The subject is 18 years old or older. (2) The subject is clinically suspected or known
to have parathyroid adenoma and is scheduled to have a MIBI study as part of his/her
standard clinical evaluation.
(3) The subject is able and willing to comply with the additional procedure (ultrafast
MIBI SPECT) and a signed and dated informed consent is obtained before any procedure for
study purposes is performed.
Exclusion Criteria:
1. Pregnancy.
2. Psychosis or any other condition, which, in the investigators opinion would prevent
adherence to the study protocol.
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypercalcemia
|
|
Hyperparathyroidism
|
|
Secondary ID(s)
|
|
024-10-RMB_parathyroid
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|